Abstract

In human glioblastoma (GBM), the presence of a small population of cells with stem cell characteristics, the glioma stem cells (GSCs), has been described. These cells have GBM potential and are responsible for the origin of the tumors. However, whether GSCs originate from normal neural stem cells (NSCs) as a consequence of genetic and epigenetic changes and/or dedifferentiation from somatic cells remains to be investigated. Genomic imprinting is an epigenetic marking process that causes genes to be expressed depending on their parental origin. The dysregulation of the imprinting pattern or the loss of genomic imprinting (LOI) have been described in different tumors including GBM, being one of the earliest and most common events that occurs in human cancers. Here we have gathered the current knowledge of the role of imprinted genes in normal NSCs function and how the imprinting process is altered in human GBM. We also review the changes at particular imprinted loci that might be involved in the development of the tumor. Understanding the mechanistic similarities in the regulation of genomic imprinting between normal NSCs and GBM cells will be helpful to identify molecular players that might be involved in the development of human GBM.

Highlights

  • Aberrations of Genomic Imprinting in Glioblastoma FormationAnna Lozano-Ureña , 1,2† Esteban Jiménez-Villalba 1†, Alejandro Pinedo-Serrano 1, Antonio Jordán-Pla 1, Martina Kirstein 1,2 and Sacri R

  • Reviewed by: Joomyeong Kim, Louisiana State University, United States Pilar Sánchez-Gómez, Instituto de Salud Carlos III (ISCIII), Spain

  • In order to further elucidate the potential regulation of genomic imprinting during malignant transformation of neural stem cells (NSCs), we performed an analysis of single-cell RNA sequencing data, which had been previously generated from 28 human GBM samples [88], and compared it with non-malignant oligodendrocytes and adult human NSCs [89]

Read more

Summary

Aberrations of Genomic Imprinting in Glioblastoma Formation

Anna Lozano-Ureña , 1,2† Esteban Jiménez-Villalba 1†, Alejandro Pinedo-Serrano 1, Antonio Jordán-Pla 1, Martina Kirstein 1,2 and Sacri R. Reviewed by: Joomyeong Kim, Louisiana State University, United States Pilar Sánchez-Gómez, Instituto de Salud Carlos III (ISCIII), Spain. Specialty section: This article was submitted to Neuro-Oncology and Neurosurgical

Frontiers in Oncology
GENOMIC IMPRINTING AND GENE DOSAGE CONTROL
IMPRINTED GENES AND NSCs
GENOMIC IMPRINTING IN HUMAN GLIOBLASTOMA
Findings
ABERRATIONS OF GENOMIC IMPRINTING IN NSCs AND GBM FORMATION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.